Company intelligence / Profile preview

Cocoon Biotech

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~8
Development stage: Other

Overview

Silk fibroin-based intra-articular product in preclinical stage for osteoarthritis; demonstrated biocompatibility, begun pivotal efficacy in large animals as of 2017; planning pre-IND and toxicology studies. Advancing drug delivery, medical devices, and sustainable ingredients for healthcare and consumer applications.

Therapeutic areas: OtherRheumatology
Modalities: BiologicDrug delivery system
Industry: Biotech

Partnerships

Camargo Pharmaceutical Services

Beyond the preview

Go deeper on Cocoon Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cocoon Biotech.

Explore the full profile